Emgality

Active Ingredient(s): Galcanezumab-gnlm
FDA Approved: * September 27, 2018
Pharm Company: * ELI LILLY AND CO
Category: Migraine / Tension Headache

Galcanezumab, sold under the brand name Emgality, is a humanized monoclonal antibody used for the prevention of migraine.[1][2] It is also used for cluster headaches.[3] Common side effects include pain or redness at the site of injection.[3][4] Other side effects may include hypersensitivity reactions.[3] A substance called calcitonin gene-related peptide (CGRP) has been shown to be involved in th... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Emgality 120 mg/ml Subcutaneous Injection, Solution

NDC: 0002-1436

Labeler:

Eli Lilly and Company

Emgality 120 mg/ml Subcutaneous Injection, Solution

NDC: 0002-2377

Labeler:

Eli Lilly and Company

Emgality 100 mg/ml Subcutaneous Injection, Solution

NDC: 0002-3115

Labeler:

Eli Lilly and Company

Dosage List

Popular Topics